In this scenario, AIM2 activation is involved in COPD exacerbation via the release of IL-1α, responsible for the induction of TGF-β, immune suppressive and pro-fibrotic cytokine. This evidence concerns the gene IL1A and chronic obstructive pulmonary disease.